Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126528831 | 12652883 | 1 | I | 20160801 | 20160815 | 20160815 | EXP | CN-SILVERGATE PHARMACEUTICALS, INC.-2016SIL00001 | SILVERGATE | LIU XW, JIN Y, LIU Z. A CASE OF SURVIVAL FOLLOWING INTAKE OF A POTENTIALLY LETHAL DOSE OF ENALAPRIL. TOXIN REV. [ARTICLE IN PRESS: DOI:10.1080/155695432.2016.1201841]. 2016 | 28.00 | YR | F | Y | 0.00000 | 20160815 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126528831 | 12652883 | 1 | PS | ENALAPRIL | ENALAPRIL | 1 | Oral | 7000 MG, ONCE | 0 | 7000 | MG | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126528831 | 12652883 | OT |
| 126528831 | 12652883 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126528831 | 12652883 | Hypotension | |
| 126528831 | 12652883 | Intentional overdose | |
| 126528831 | 12652883 | Metabolic acidosis | |
| 126528831 | 12652883 | Oedema | |
| 126528831 | 12652883 | Pleural effusion | |
| 126528831 | 12652883 | Poisoning | |
| 126528831 | 12652883 | Renal impairment | |
| 126528831 | 12652883 | Respiratory failure | |
| 126528831 | 12652883 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |